Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Minerva Medica|November 1, 1988
[Normally functioning goiter: reflections on the clinical course. A 30-year follow up]G Trotti, P Marinoni, C BorriMinerva Medica|March 10, 1983
[Hypercalcemic syndrome in malignant lymphomas. Review of the literature and clinical contribution]L Montalbetti, G Crovetti, R Stella, et al.International Journal of Oncology|March 16, 2000
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancerA Riccardi, C Tinelli, S Brugnatelli, et al.British Journal of Cancer|March 1, 1996
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple MyelomaS Brugnatelli, A Riccardi, G Ucci, et al.British Journal of Cancer|July 20, 2001
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)A Riccardi, P Pugliese, M Danova, et al.Tumori|December 23, 1998
Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast CancerA Riccardi, S Brugnatelli, M Giordano, et al.Pageof 1